[{"indications": "Indications\u00a0adjunct in the treatment of Plasmodium vivax and P. ovale malaria (eradication of liver stages)", "name": "PRIMAQUINE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.4 Antiprotozoal drugs", "5.4.1 Antimalarials", "Primaquine"], "cautions": "Cautions\u00a0G6PD deficiency (test blood, see under Benign Malarias (treatment)); systemic diseases associated with granulocytopenia (e.g. rheumatoid arthritis, lupus erythematosus); interactions: Appendix 1 (primaquine)", "side-effects": "Side-effects\u00a0nausea, vomiting, anorexia, abdominal pain; less\r\ncommonly methaemoglobinaemia, haemolytic anaemia especially in G6PD\r\ndeficiency, leucopenia", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/4021.htm", "doses": ["Treatment of benign malarias, see notes above"], "pregnancy": "Pregnancy\u00a0risk of neonatal haemolysis and methaemoglobinaemia\r\nin third trimester; see also Benign Malarias (treatment)"}]